J Oldgren
Overview
Explore the profile of J Oldgren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proietti M, Hijazi Z, Andersson U, Connolly S, Eikelboom J, Ezekowitz M, et al.
J Intern Med
. 2017 Oct;
283(3):282-292.
PMID: 29044861
Background: Oral anticoagulation is the mainstay of stroke prevention in atrial fibrillation (AF), but must be balanced against the associated bleeding risk. Several risk scores have been proposed for prediction...
2.
Westenbrink B, Alings M, Connolly S, Eikelboom J, Ezekowitz M, Oldgren J, et al.
J Thromb Haemost
. 2015 Feb;
13(5):699-707.
PMID: 25683276
Background: Anemia may predispose to thromboembolic events or bleeding in anticoagulated patients with atrial fibrillation (AF). Objectives: To investigate whether anemia is associated with thromboembolic events and bleeding in patients...
3.
Hedberg J, Sundstrom J, Thuresson M, Aarskog P, Oldgren J, Bodegard J
J Intern Med
. 2013 Jun;
274(4):371-80.
PMID: 23800296
Objective: The aim of this study was to investigate the associations between proton pump inhibitor (PPI) usage patterns and risk of severe gastrointestinal events in patients treated with low-dose acetylsalicylic...
4.
Sinnaeve P, Brueckmann M, Clemens A, Oldgren J, Eikelboom J, Healey J
J Intern Med
. 2011 Oct;
271(1):15-24.
PMID: 21995885
Elderly patients with atrial fibrillation (AF), who constitute almost half of all AF patients, are at increased risk of stroke. Anticoagulant therapies, especially vitamin K antagonists (VKA), reduce the risk...
5.
Christersson C, Oldgren J, Wallentin L, Siegbahn A
J Intern Med
. 2011 Jan;
270(3):215-23.
PMID: 21255134
Background: Thrombin has a role not only in the coagulation process but also in inflammatory responses. Oral direct thrombin inhibitors (DTIs) are currently being evaluated in patients with thromboembolic diseases....
6.
Psaty B, Furberg C, Khaw K, Sandhu M, Oldgren J, Rossi G, et al.
Eur J Cardiovasc Prev Rehabil
. 2007 Feb;
14(1):3-11.
PMID: 17301621
Background: A large number of observational epidemiological studies have reported generally positive associations between circulating mass and activity levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) and the risk of cardiovascular diseases....
7.
Oldgren J, Fellenius C, Boman K, Jansson J, Nilsson T, Wallentin L, et al.
J Intern Med
. 2005 Oct;
258(5):420-7.
PMID: 16238677
Background: Unstable coronary artery disease (CAD) is a multi-factorial disease involving thrombotic and inflammatory processes. Short-term low molecular weight (LMW) heparin treatment reduces coagulation activity and clinical events. We investigated...
8.
Christersson C, Oldgren J, Bylock A, Wallentin L, Siegbahn A
J Thromb Haemost
. 2005 Oct;
3(10):2245-53.
PMID: 16194202
Background: In the ESTEEM study, patients with a recent myocardial infarction were treated with aspirin and randomized to one of four doses (24-60 mg b.i.d) of the oral direct thrombin...
9.
Johansson J, Hammerby R, Oldgren J, Rubertsson S, Gedeborg R
Acta Anaesthesiol Scand
. 2004 Jul;
48(7):909-13.
PMID: 15242439
Background: Adrenaline does not appear to improve the outcome after cardiac arrest in clinical trials in spite of beneficial effects in experimental studies. The objective of this study was to...
10.
Oldgren J, Wallentin L, Grip L, Linder R, Norgaard B, Siegbahn A
Eur Heart J
. 2003 Feb;
24(1):86-93.
PMID: 12559940
Aim: Unstable coronary artery disease (CAD) is a multifactorial disease involving both thrombotic and inflammatory processes. We have assessed the time-course and the influence of thrombin inhibitors on changes in...